OBJECTIVE: To investigate the risks of height, weight and body fat distribution associated with colon cancer in subcategories of gender, age and site in the colon. Interaction with family history of colorectal cancer is also examined. DESIGN: Case-control study of diet, anthropometry and colon cancer risk. SUBJECTS: Nineteen hundred and eighty-three colon cancer cases (age 30±79 y) and 2400 age and gender matched population controls. MEASUREMENTS: Height, weight and waist and hip circumferences were obtained by trained interviewers. Body Mass Index (BMI) and Waist-Hip Ratio (WHR) were calculated. RESULTS: Of all anthropometric measurements examined, only BMI was consistently associated with an increased risk of colon cancer. The test for trend for BMI was signi®cant for men and women overall and for the majority of subgroups examined. In younger persons those with a family history of colorectal cancer had a greater risk of colon cancer associated with BMI (Men odds ratio (OR) 7.76, 95% con®dence interval (CI) 2.60, 23.1; Women OR 4.85, 95% CI 2.33, 10.12) comparing the third tertile to the ®rst, than those with no family history (Men OR 1.70 95% CI 1.25, 2.32; Women OR 1.53 95% CI 1.22, 1.92). WHR, after controlling for BMI was not associated with colon cancer in men, and was associated with a slight increase in women (primarily in those with distal tumors). CONCLUSION: This study contributes to mounting evidence that excess weight is associated with an increased risk of colon cancer.
Introduction
Height, weight, and body fat distribution have been reported to be associated with the risk of colorectal cancer. Height, in some studies is positively related to colon or colorectal cancer, especially in men, with the effect in women weak or absent. 1±5 Several studies have found a positive association of increasing weight or body mass index (BMI) with risk of colon cancer. 4 ,6±8 However, in some studies, no association has been found 6 and recently one study found men who developed colon cancer weighed slightly less than those who did not. 9 The independent effect of body fat distribution has been reported in few studies of colon cancer. 4, 7 Bostick et al, 7 found that waist to hip ratio (WHR) was not related to risk of colon cancer in women. Giovannucci et al 4 found that WHR in men was positively related to colon cancer, only when those with the highest WHR were compared to those with the lowest WHR. The test for trend was not signi®cant.
The effects of risk factors for colon cancer, other than anthropometric ones, have been reported in some studies to vary by gender, age or site in the colon 6,10±12 . Colonic metabolism and rates of proximal and distal cancers differ between the genders. 13 Few studies have investigated risk from body size in colon subsites. 5, 10, 14 To our knowledge, no studies have investigated the possibility of effect modi®cation by family history. Here we examine the relationship of height, BMI, waist circumference and WHR, to colon cancer by gender, site and age, and the possible role of a family history of colorectal cancer in modifying these relationships.
Methods
The study design has been reported in detail elsewhere. 15 Brie¯y, a case-control study of colon cancer cases (ICD-0, 2nd edition codes 18.0, 18.2 to 18.9) of patients aged between 30±79 y diagnosed between October 1991 and September 1994, was conducted in Utah, the Twin Cities area of Minnesota, and Northern California. Controls were chosen to represent the geographic and age-gender distribution of cases. The study sample was 91% white non-Hispanic.
Of those we could contact, 76% of cases and 64% of controls completed the interview.
Data were collected by trained and certi®ed interviewers using laptop computers within three months of diagnosis for cases. The referent period that study participants were asked to recall was the year, two years prior to the index date (the date of diagnosis for cases or the date of selection for controls). The interview took approximately two hours to complete. Quality control methods used have been described. 16 Body size measurements were obtained during the in-home interview. Standing height was measured without shoes to the nearest 0.25 inch with the participant standing against a wall or door jamb. A 90 triangle was placed against the door jamb and on top of the head, and the location marked on the door jamb ± height was then determined by a tape measure. Waist circumference was measured one inch above the umbilicus, and hip circumference was measured at the fullest point using¯exible tape measures marked in cm. Two measurements were taken and if they varied by more than 10 mm, a third was taken. The average of the two closest measurements was calculated. Current weight was measured to the nearest pound on portable scales. The participant recalled his or her weight one, two and ®ve years prior to the interview. Weight two years ago was considered a better indicator of pre-diagnosis weight than current weight would be. BMI for two years prior to the index date was calculated as kgam 2 
.
In 1% of the sample, weight from two years ago was missing so weight from ®ve years ago was substituted in the BMI calculation. Some investigators have suggested that waist circumference alone is a better indicator of visceral fat than WHR since it is more highly correlated with insulin and cholesterol levels. 17±19 However, in this study WHR was chosen as our indicator of body fat distribution since waist circumference was more sensitive than WHR to bias from weight loss that may have occurred due to wasting.
Dietary intake data were collected using an adaptation of the CARDIA (Coronary Artery Risk Development in Young Adults) diet history. 20, 21 Information collected on many speci®c foods included how often they were eaten, the amount, whether fat was added in preparation and for some foods, whether anything was added. Daily nutrient intake was derived. In addition to dietary intake, other data used were physical activity, medication usage, smoking history and family history of colorectal cancer. Participants were asked the frequency and duration of speci®c vigorous leisure time physical activities during the referent period, and all vigorous leisure activity ten and twenty years ago. A summary longterm vigorous leisure physical activity variable was derived. Participants were asked if they ever took speci®c medications at least three times a week for at least one month and whether they had ever smoked at least 100 cigarettes, and if so, how much they usually smoked and how many years during their lives they smoked. Participants reported whether colorectal cancer had been diagnosed in their parents, siblings or children.
Statistical analysis
Persons with missing BMI data (20 people) were excluded from these analyses. We also eliminated waist and WHR data for 538 persons whose waist and hip measurements were taken by one interviewer who did not rigorously follow study protocols and whose data was found to be unreliable. Analyses were strati®ed by gender. Each of the body size measures were categorized into quintiles based upon the genderspeci®c distribution in the control population. Because circumference measures were obtained after the case diagnosis when weight loss could have occurred due to the disease or its treatment, we examined waist circumference and WHR including and excluding people whose weight at the interview changed 10% or more compared to that reported two years earlier.
Odds ratios (ORs) obtained from unconditional multiple logistic regression models were used to estimate relative risk of colon cancer associated with body size. Those non-anthropometric variables which demonstrated an association in our data were included in the adjusted models as potential confounders, they included: age at selection; whether the subject had ever regularly used aspirin andaor other non-steroidal anti-in¯ammatory medications; intake of energy; dietary ®ber and calcium; long-term vigorous leisure physical activity (categorized as low, medium or high) and whether any ®rst-degree relatives had colorectal cancer. BMI was included in the WHR analysis. Smoking, alcohol and hormone replacement therapy were examined as covariates but did not confound any relationships and were therefore not included in the ®nal models. Tests for trend were performed by modelling the variable of interest as a continuous variable. Further analyses were strati®ed by age in three categories or by site of the colon tumor (distal colon sigmoid, descending and splenic¯exure, proximal colon cecum through transverse colon excluding appendix) since this was an a priori goal of the study.
To test for the interaction between age and each of the body size variables: height, BMI or WHR, interaction terms for three levels of age and ®ve levels of body size variables were constructed and a Wald chi square test was evaluated for their addition to the model. To investigate the interaction between family history of colorectal cancer and each of the body size variables: height, BMI or WHR, we examined the P value for a multiplicative interaction term added to fully adjusted models separately in age groups 567, !67 (the median age of the controls). Where there was a signi®cant interaction, ORs for tertiles were calculated.
Results Table 1 presents the distribution of body size variables in cases vs controls. Mean weight, BMI and WHR in both men and women were signi®cantly higher in cases than controls. No signi®cant differences existed for height, or waist circumference. Table 2 presents ORs by gender for quintiles of body size variables, adjusted for non-anthropometric confounders. Height was not signi®cantly related to colon cancer. Weight and BMI were signi®cantly related to colon cancer, with ORs both of almost 2.0 in men and 1.5 in women for the highest quintile compared to the lowest. Waist circumference was related in men only when excluding those men whose two year weight change was 10% or more. WHR was related in men and women and the relationship was changed little by restricting to those whose weight change was 10% or more. Adjusted for age at selection; ever regularly used aspirin andaor non-steroidal anti-in¯ammatory medications; intake of dietary energy, ®ber and calcium; history of colorectal cancer in ®rst-degree relative and category of long-term vigorous leisure activity. Excludes persons whose weight changed 4 10% from reported weight 2 years ago to measured weight at interview. OR odds ratio; Cl 95% con®dence interval.
BMI
Risk of colon cancer increased signi®cantly with higher BMI (Table 3) . Although in both men and women the test for interaction with age (men p 0.76, women p 0.14) was not signi®cant, it appeared that the association with BMI was stronger in certain age categories. The relationship was statistically signi®-cant only in men 455 y and women 570 y. For men, the relationship was strongest in the 55±69 y age group and for women, the relationship was the strongest in the 30±54 y age group. ORs rose more with increasing quintiles in distal than in proximal tumors for men and for women.
In younger men and women there were signi®cant interactions with family history (men P50.05, women P50.01). In younger men with a positive family history, the OR (95% con®dence interval (CI)) for the highest tertile compared to the lowest was 7.76 (2.60, 23.1) compared to values of those with a negative family history, 1.70 (1.25, 2.32) (data not shown). In younger women with a positive family history, the OR (95% CI) for the highest tertile compared to the lowest was 4.85 (2.33, 10.12) compared to values of 1.53 (1.22, 1.92) for those with a negative family history (data not shown).
WHR
When controlled for BMI, there was no WHR relationship found for men, for any age group, nor for a speci®c site in the colon (Table 4 ). The only signi®-cant ®ndings were in women and it appears that most of the observed risk was attributed to those with distal tumors. ORs for the ®fth quintile compared to the ®rst quintile were elevated in all subgroups but only reached statistical signi®cance for those with distal tumors where the OR was 1.97. No signi®cant interaction with family history was found for either age group of men or women.
Discussion
Our lack of association between height and colon cancer is consistent with the some studies 1, 2, 5 and is in contrast to others which have demonstrated a positive association 3, 14 Our height analysis did not include BMI as a covariate because height is included in the denominator when calculating BMI. Three previously cited studies 1,2,14 controlled for BMI and this in part could explain inconsistent results among studies.
Height is potentially important because it has been theorized that men who are taller have longer colons with more cells for exposure to potential carcinogens and that shorter men may have stunted growth from energy restriction which also may decrease later colon cancer risk. 6 Our ®nding of increased risk in men with higher BMI agrees with most other studies, 4,8,10,22±26 although some have reported no signi®cant relationship 27, 28 and one has reported an inverse relationship. 9 Our positive results in women agree with some authors, 5, 7, 10, 22, 26 but contrast with others who did not ®nd a signi®cant relationship. 14, 23, 25, 27, 28 Of interest in our data was the ®nding that BMI was not related to colon cancer risk in older women. Perhaps this could explain some of the null ®ndings in other studies. We did not ®nd any studies for comparison which examined risk from BMI strati®ed on age at diagnosis.
Our ®nding of a positive association between BMI and risk of cancer in the distal colon for men and women is consistent with the majority of studies. a Adjusted for age at selection; ever regularly used aspirin andaor non-steroidal anti-in¯ammatory medications; intake of dietary energy, ®ber and calcium; history of colorectal cancer in ®rst-degree relative and category of long-term vigorous leisure activity. OR odds ratio. CI 95% con®dence interval.
5,22,29
One fairly small study found a statistically signi®cant increased risk for women but not for men 10 and one found no relationship for women.
14 Our ®nding of signi®cantly increased risk in association with proximal sites contrasts with other studies which found no relationship. 5, 10, 14, 22 One explanation for varying results could be different de®nitions for the cut-off point between proximal and distal and whether transverse colon is examined separately.
The role of body mass in the etiology of colon cancer may have more to do with a speci®c metabolic pro®le than local in¯uences on the colonic epithelium. McKeown-Eyssen 30 has proposed that some factors that are associated with increased risk such as obesity may plausibly operate through in¯uences upon serum triglycerides and insulin resistance (Syndrome X) more commonly associated with coronary heart disease and diabetes mellitus than colon cancer. She argues further that such a metabolic pro®le may well act as a promotional milieu for cells thus parallelling, but making more speci®c, earlier proposals of McMichael and Potter 13, 31 . Finally, McKeownEyssen 30 proposes that such a growth-promoting milieu might act speci®cally to bene®t neoplastic cells.
Another possibility is that obesity is part of an adverse colon cancer risk lifestyle pattern, which includes inactivity and a diet high in fat and calories and low in fruits and vegetables. Statistical control for these other lifestyle factors may not be adequate to establish an independent effect of obesity since they are often highly correlated.
We were able to identify only two other studies, both prospective, which examined WHR and colon cancer risk. Bostick et al 7 who studied only women and did not adjust for BMI, found a nonsigni®cant increase in women only with the highest WHR. In contrast, we found elevated risks in all quintiles above the ®rst and a signi®cant test for trend. However, most of that increased risk was attributed to those with distal tumors. Giovannucci et al 4 studying only men and controlling for BMI, found a signi®cant relationship when the ®fth quintile of WHR was compared to the ®rst, but found, as we did, no signi®cant trend for WHR. Our ®nding in women must be taken with caution, since we had to remove 118 cases and 127 controls due to unreliable WHR data provided by one interviewer. When those women were included in the analysis, the test for trend was no longer signi®cant. The removal of unreliable data from men did not alter the results.
One drawback of our study is not having prospectively collected waist and hip circumference information. Many people lose weight after colon cancer develops, and waist circumference and WHR may decrease. This would tend to obscure any relationship with pre-diagnosis values. However, when we eliminated those whose weight had changed 10% or more, the magnitude of the relationship with WHR in both genders changed only minimally. In addition, some studies have shown only minor changes in WHR in response to weight loss. 32 Even with the limitations of the WHR data noted above, we have reported on this for several reasons. There is limited data in this area and no one has previously examined site-speci®c associations. Additionally we have demonstrated the importance of controlling for BMI when evaluating the contribution of WHR. WHR is a strong predictor of colon cancer before control for BMI. After control, the relationship disappeared for men and in women was greatly attenuated.
Given our response rates of 76% for cases and 64% for controls, it is possible that participation was related to body size, so that heavier people would be less likely to participate. If this were true of both cases and controls, our results would not change. However if this was true of only controls, our ®ndings would overestimate the true risk. This study contributes to mounting evidence that excess weight as indicated by BMI in this study is associated with increased colon cancer risk. We present evidence that excess weight may have its greatest impact in men aged 55±69 y and in young (aged 30± 54 y), most likely pre-menopausal women. In younger people, excess weight may be more detrimental in those with a family history of colorectal cancer than those without a family history of colorectal cancer. Efforts to reduce obesity may reduce risk of colon cancer.
